
Suhan Ni
Examiner (ID: 3854)
| Most Active Art Unit | 2656 |
| Art Unit(s) | 2691, 2615, 2643, 2614, 2656, 2651, 2743, 2646 |
| Total Applications | 2030 |
| Issued Applications | 1623 |
| Pending Applications | 153 |
| Abandoned Applications | 292 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5924265
[patent_doc_number] => 20060241104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Oxalamide derivatives as kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/406795
[patent_app_country] => US
[patent_app_date] => 2006-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10413
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20060241104.pdf
[firstpage_image] =>[orig_patent_app_number] => 11406795
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/406795 | Oxalamide derivatives as kinase inhibitors | Apr 18, 2006 | Issued |
Array
(
[id] => 5620047
[patent_doc_number] => 20060189581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Compounds and methods for treating transplant rejection'
[patent_app_type] => utility
[patent_app_number] => 11/405798
[patent_app_country] => US
[patent_app_date] => 2006-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10917
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20060189581.pdf
[firstpage_image] =>[orig_patent_app_number] => 11405798
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/405798 | Compounds and methods for treating transplant rejection | Apr 17, 2006 | Abandoned |
Array
(
[id] => 5609177
[patent_doc_number] => 20060270693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Ether derivative'
[patent_app_type] => utility
[patent_app_number] => 11/402958
[patent_app_country] => US
[patent_app_date] => 2006-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 26319
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20060270693.pdf
[firstpage_image] =>[orig_patent_app_number] => 11402958
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/402958 | Ether derivative | Apr 12, 2006 | Issued |
Array
(
[id] => 5285556
[patent_doc_number] => 20090099231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => '3-Sulfonylamino-Pyrrolidine-2-One Derivatives as Factor Xa Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/911162
[patent_app_country] => US
[patent_app_date] => 2006-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26376
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20090099231.pdf
[firstpage_image] =>[orig_patent_app_number] => 11911162
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/911162 | 3-Sulfonylamino-Pyrrolidine-2-One Derivatives as Factor Xa Inhibitors | Apr 6, 2006 | Abandoned |
Array
(
[id] => 270553
[patent_doc_number] => 07563789
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-21
[patent_title] => '1-Adamantyl chalcones for the treatment of proliferative disorders'
[patent_app_type] => utility
[patent_app_number] => 11/400506
[patent_app_country] => US
[patent_app_date] => 2006-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15556
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/563/07563789.pdf
[firstpage_image] =>[orig_patent_app_number] => 11400506
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/400506 | 1-Adamantyl chalcones for the treatment of proliferative disorders | Apr 6, 2006 | Issued |
Array
(
[id] => 5890103
[patent_doc_number] => 20060276505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Acylhydrazine P2X7 antagonists and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/400492
[patent_app_country] => US
[patent_app_date] => 2006-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24125
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20060276505.pdf
[firstpage_image] =>[orig_patent_app_number] => 11400492
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/400492 | Acylhydrazine P2X7 antagonists and uses thereof | Apr 6, 2006 | Abandoned |
Array
(
[id] => 5620127
[patent_doc_number] => 20060189661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/398556
[patent_app_country] => US
[patent_app_date] => 2006-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67094
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20060189661.pdf
[firstpage_image] =>[orig_patent_app_number] => 11398556
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/398556 | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists | Apr 5, 2006 | Abandoned |
Array
(
[id] => 4873786
[patent_doc_number] => 20080200520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'Iron Modulators'
[patent_app_type] => utility
[patent_app_number] => 11/886879
[patent_app_country] => US
[patent_app_date] => 2006-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 11010
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0200/20080200520.pdf
[firstpage_image] =>[orig_patent_app_number] => 11886879
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/886879 | Iron Modulators | Mar 30, 2006 | Abandoned |
Array
(
[id] => 5875282
[patent_doc_number] => 20060166978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Substituted beta carbolines'
[patent_app_type] => utility
[patent_app_number] => 11/390287
[patent_app_country] => US
[patent_app_date] => 2006-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18273
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20060166978.pdf
[firstpage_image] =>[orig_patent_app_number] => 11390287
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/390287 | Substituted β-carbolines | Mar 27, 2006 | Issued |
Array
(
[id] => 4808303
[patent_doc_number] => 20080171881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-17
[patent_title] => 'Method for Producing Organic Compound and Method for Decomposing Compound Having Dicarboximide Skeleton'
[patent_app_type] => utility
[patent_app_number] => 11/885125
[patent_app_country] => US
[patent_app_date] => 2006-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17573
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20080171881.pdf
[firstpage_image] =>[orig_patent_app_number] => 11885125
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/885125 | Method for producing organic compound and method for decomposing compound having dicarboximide skeleton | Mar 21, 2006 | Issued |
Array
(
[id] => 4456380
[patent_doc_number] => 07893093
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-22
[patent_title] => 'Sulfonyl containing compounds as cysteine protease inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/909053
[patent_app_country] => US
[patent_app_date] => 2006-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32362
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/893/07893093.pdf
[firstpage_image] =>[orig_patent_app_number] => 11909053
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/909053 | Sulfonyl containing compounds as cysteine protease inhibitors | Mar 21, 2006 | Issued |
Array
(
[id] => 5859669
[patent_doc_number] => 20060229206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Acylated thiosemicarbazides as herbicides'
[patent_app_type] => utility
[patent_app_number] => 11/386499
[patent_app_country] => US
[patent_app_date] => 2006-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5360
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20060229206.pdf
[firstpage_image] =>[orig_patent_app_number] => 11386499
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/386499 | Acylated thiosemicarbazides as herbicides | Mar 21, 2006 | Issued |
Array
(
[id] => 131937
[patent_doc_number] => 07700631
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-20
[patent_title] => 'Phosphodiesterase 4 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/378615
[patent_app_country] => US
[patent_app_date] => 2006-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15898
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/700/07700631.pdf
[firstpage_image] =>[orig_patent_app_number] => 11378615
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/378615 | Phosphodiesterase 4 inhibitors | Mar 19, 2006 | Issued |
Array
(
[id] => 5113649
[patent_doc_number] => 20070197565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'Bicycloheteroaryl compounds as P2X7 modulators and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/384199
[patent_app_country] => US
[patent_app_date] => 2006-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27859
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20070197565.pdf
[firstpage_image] =>[orig_patent_app_number] => 11384199
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/384199 | Bicycloheteroaryl compounds as P2X7 modulators and uses thereof | Mar 16, 2006 | Issued |
Array
(
[id] => 5452107
[patent_doc_number] => 20090068144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'TETRAHYDRO-ISOQUINOLIN-1-ONES FOR THE TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 11/909014
[patent_app_country] => US
[patent_app_date] => 2006-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7085
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20090068144.pdf
[firstpage_image] =>[orig_patent_app_number] => 11909014
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/909014 | Tetrahydro-isoquinolin-1-ones for the treatment of cancer | Mar 16, 2006 | Issued |
Array
(
[id] => 5620125
[patent_doc_number] => 20060189659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione maleic acid salt'
[patent_app_type] => utility
[patent_app_number] => 11/377470
[patent_app_country] => US
[patent_app_date] => 2006-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2297
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20060189659.pdf
[firstpage_image] =>[orig_patent_app_number] => 11377470
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/377470 | Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione maleic acid salt | Mar 15, 2006 | Abandoned |
Array
(
[id] => 22822
[patent_doc_number] => 07799926
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-21
[patent_title] => 'Polar dyes'
[patent_app_type] => utility
[patent_app_number] => 11/372249
[patent_app_country] => US
[patent_app_date] => 2006-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 29626
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/799/07799926.pdf
[firstpage_image] =>[orig_patent_app_number] => 11372249
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/372249 | Polar dyes | Mar 8, 2006 | Issued |
Array
(
[id] => 373403
[patent_doc_number] => 07473706
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-01-06
[patent_title] => 'Compounds that stimulate glucose utilization and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/369182
[patent_app_country] => US
[patent_app_date] => 2006-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10734
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/473/07473706.pdf
[firstpage_image] =>[orig_patent_app_number] => 11369182
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/369182 | Compounds that stimulate glucose utilization and methods of use | Mar 5, 2006 | Issued |
Array
(
[id] => 5096213
[patent_doc_number] => 20070117822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-24
[patent_title] => 'Novel antimalarial baylis-hillman adducts and a process for the preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 11/366672
[patent_app_country] => US
[patent_app_date] => 2006-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15679
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20070117822.pdf
[firstpage_image] =>[orig_patent_app_number] => 11366672
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/366672 | Antimalarial Baylis-Hillman adducts and a process for the preparation thereof | Mar 2, 2006 | Issued |
Array
(
[id] => 4779463
[patent_doc_number] => 20080287461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'Pyridinone Derivatives Against Malaria'
[patent_app_type] => utility
[patent_app_number] => 11/817508
[patent_app_country] => US
[patent_app_date] => 2006-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33536
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20080287461.pdf
[firstpage_image] =>[orig_patent_app_number] => 11817508
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/817508 | Pyridinone derivatives against malaria | Mar 1, 2006 | Issued |